For this proof-of-concept study, we used the extensively characterized Ctsd KO mouse model- which illustrates the neuropathology of human neuronal ceroid lipofuscinosis type 10- given the presence of prominent SNCA aggregation in the brain [45, 66]. The gene discussed is CTSD; the disease is neuronal ceroid lipofuscinosis 10.